REFERENCES
- Spitzer A, Edelman CM, Goldberg LD, Henneman PH. Short stature, hyperkalemia, and acidosis: a defect in renal transport of potassium. Kidney Int. 1973; 3: 251–257
- Wu MS, Hong JJ, Lin JL, Yang CW, Chien HC. Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium. Nephrol Dial Transplant. 1996; 11: 867–870
- Colussi G, Rombola G, Brunati, De Ferrari ME. Abnormal reabsorption of Na+/CI- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome. Am J Nephrol. 1997; 17(2)103–111
- Achard JM, Warnock DG, Disse-Nicodeme S, et al. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation. Am J Med. 2003; 114: 495–498
- Gordon RD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension. 1986; 8: 93–102
- Rodriguez SJ. Renal tubule acidosis: the clinical entity. J Am Soc Nephrol. 2002; 13(8)2160–2170
- Yang CL, Angel J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest. 2003; 111: 1039–1045
- Wilson FH, Nicodeme SD, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001; 293: 1107–1112
- Gamba G. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. AJP Renal. 2005; 288: 245–252
- Ganguly G. Aldosterone. Endocrine Regulation of Water and Electrolyte Balance, JCS Fray, HM Goodman. Oxford University Press, New York 2000; 3: 156–227